recent
FDA Approves IND Application for Freedom’s Ketamine-Based Combination Therapy
Lykos Completes European Phase 2 Study for MDMA-Assisted Therapy
Numinus Plans to Refocus on U.S. Market, Considers Divesting Canadian Operations
Cybin Receives New Patent for Psilocybin Depression Treatment
